10x Genomics, Inc. — Director's Dealing 2025

Mar 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2025-03-17

Reporting Person: Saxonov Serge (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-17	Class A Common Stock	A	171428	—	Acquired	1092968	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	27	Indirect
Class A Common Stock	870	Indirect
Class A Common Stock	213250	Indirect
Class A Common Stock	22570	Indirect

Footnotes

F1: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date.

F2: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

F3: The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.

F4: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

F5: The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.